Cytokinetics Inc (CYTK)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -536,248 | -496,205 | -324,202 | -186,313 | -93,943 |
| Total assets | US$ in thousands | 1,401,670 | 824,316 | 1,014,780 | 841,319 | 533,803 |
| Operating ROA | -38.26% | -60.20% | -31.95% | -22.15% | -17.60% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $-536,248K ÷ $1,401,670K
= -38.26%
Cytokinetics Inc's operating return on assets (Operating ROA) has shown a declining trend over the years. Starting at -17.60% on December 31, 2020, the Operating ROA decreased to -22.15% by December 31, 2021, indicating a decrease in the company's ability to generate operating profit from its assets. Subsequently, the metric decreased further to -31.95% by the end of 2022, -60.20% by the end of 2023, and finally to -38.26% by the end of 2024. This consistent downward trend in Operating ROA suggests inefficiencies or challenges in utilizing the company's assets to generate operating profits during the specified period. Further analysis of the company's operations and asset management strategies may be necessary to address these deteriorating performance indicators.
Peer comparison
Dec 31, 2024